Liqomics GmbH
About
At LIQOMICS, we strive to improve cancer treatment. Using a simple blood sample, we analyze circulating tumor DNA (ctDNA) to understand the genetic characteristics of individual tumors. With this liquid biopsy, genetic changes in a tumor can be detected and the amount of remaining tumor can be determined very precisely.
Areas of activity
LIFE SCIENCE
DiagnosticsMedical Services
THERAPEUTIC AREA
DiagnosticsHematologyOncology
MEDICINE
Diagnostics, Diagnosis
Representatives
Managing Director
Liqomics GmbH